Heart Failure Clinical Trial

The Effects of Self-monitoring With a Mobile Application in Heart Failure

Summary

In the United States, about 40 percent of heart failure (HF) patients are readmitted within 1-year following their first admission for HF and hospitalization accounts for approximately 70 percent of the costs of HF management. As a result, the management of HF patients is evolving from the traditional model of face-to-face follow-up visits toward a proactive real-time technological model of assisting patients with monitoring and self-management while in the community. The investigators plan to test the impact of a mobile application on clinical outcomes in HF.

View Full Description

Full Description

HF patients with a reduced ejection fraction will be randomized to the mobile application versus placebo for 12 weeks. The mobile application will provide the participants with a reminder to perform self-monitoring, a health status indicator and heart failure education for self-management.

All participants will complete the Minnesota Living with Heart Failure Questionnaire and Self-Care Heart Failure Index. Hospital admissions and mortality will also be collected.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

45 years old or older
Left ventricular ejection fraction 40% (with left atrial size >40mm or BNP > 200 pg/ml or NT-proBNP > 800 pg/ml)
Admitted for acutely decompensated heart failure or recently discharged in the past 4 weeks.
Smartphone (iOS or Android) with home wifi

Exclusion Criteria:

Unstable coronary syndrome within 8 weeks (unstable angina, NSTEMI, STEMI)
Primary valvular heart disease
Known pericardial disease (Sarcoidosis, amyloidosis, rheumatoid arthritis, lupus)
Uncorrected thyroid disease
Advanced renal disease (dialysis or creatinine >4.0 mg/dL)
End-stage HF (hospice candidate, home milrinone or dobutamine)
Active cancer
Pulmonary fibrosis
Discharge to a setting other than home

Study is for people with:

Heart Failure

Estimated Enrollment:

83

Study ID:

NCT03149510

Recruitment Status:

Completed

Sponsor:

University of Michigan

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Michigan
Ann Arbor Michigan, 48109, United States
University of Michigan Health System
Ann Arbor Michigan, 48109, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

83

Study ID:

NCT03149510

Recruitment Status:

Completed

Sponsor:


University of Michigan

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider